Literature DB >> 10910271

Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy.

J J Yun1, M P Fischbein, H Laks, M C Fishbein, M L Espejo, K Ebrahimi, Y Irie, J Berliner, A Ardehali.   

Abstract

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains the leading cause of late mortality in heart transplant recipients. Activated T lymphocytes and macrophages infiltrate the donor heart before vascular intimal thickening develops, but the specific mediators of mononuclear cell recruitment leading to CAV are unknown. Therefore, we sought to define the relationship between chemokine gene expression and production, T lymphocyte and macrophage recruitment, and intimal thickening in a murine model of CAV.
METHODS: B10.A or B10.BR strain hearts were transplanted heterotopically into B10.BR mice. Recipients were killed at 1, 4, 7, 14, and 30 days. Donor hearts were assayed for chemokine gene expression with ribonuclease protection and for protein with ELISA. Intragraft cellular infiltration was defined immunohistochemically. Intimal thickening was quantitated morphometrically.
RESULTS: Early and late patterns of intragraft chemokine expression associated with distinct cellular infiltration were identified. First, transient MIP-2 and MCP-1/JE production in isografts and allografts correlated with neutrophil and macrophage infiltration. MCP-1/JE production and macrophage infiltration was greater in allografts than isografts. Second, allografts demonstrated sustained lymphotactin, RANTES, and IP-10 expression, beginning at day 4, correlating with persistent macrophage and T lymphocyte infiltration. Intimal thickening became evident at 14 days. Isografts did not display the late pattern of sustained chemokine gene expression, cellular infiltration, or intimal thickening.
CONCLUSIONS: Transient, early MIP-2, and MCP-1/JE production in isografts and allografts correlated with neutrophil and macrophage recruitment, and is likely related to ischemia-reperfusion. In allografts, the delayed induction of chemokines specific for macrophages and T lymphocytes correlated with mononuclear cell infiltration and preceded intimal thickening. This study thus demonstrates a dual pattern of chemokine induction correlating with intragraft mononuclear cell recruitment, associated with ischemia-reperfusion and CAV development. Chemokine-directed interventions may interfere with leukocyte trafficking and inhibit CAV development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910271     DOI: 10.1097/00007890-200006270-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 2.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

3.  The role of MIG/CXCL9 in cardiac allograft vasculopathy.

Authors:  James J Yun; Michael P Fischbein; David Whiting; Yoshihito Irie; Michael C Fishbein; Marie D Burdick; John Belperio; Robert M Strieter; Hillel Laks; Judith A Berliner; Abbas Ardehali
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

4.  CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease.

Authors:  Koichi Shimizu; Manabu Minami; Rica Shubiki; Marco Lopez-Ilasaca; Lindsey MacFarlane; Yukiko Asami; Yuxin Li; Richard N Mitchell; Peter Libby
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

Review 5.  Chemokines and transplant vasculopathy.

Authors:  John A Belperio; Abbas Ardehali
Journal:  Circ Res       Date:  2008-08-29       Impact factor: 17.367

Review 6.  Chemokine-directed strategies to attenuate allograft rejection.

Authors:  Austin D Schenk; Joshua M Rosenblum; Robert L Fairchild
Journal:  Clin Lab Med       Date:  2008-09       Impact factor: 1.935

Review 7.  Fine tuning the transcriptional regulation of the CXCL1 chemokine.

Authors:  Katayoun Izadshenas Amiri; Ann Richmond
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2003

8.  Inflammation in cardiovascular tissue engineering: the challenge to a promise: a minireview.

Authors:  Agneta Simionescu; Jason B Schulte; George Fercana; Dan T Simionescu
Journal:  Int J Inflam       Date:  2011-07-09

9.  Macrophage depletion of CMV latently infected donor hearts ameliorates recipient accelerated chronic rejection.

Authors:  Nicole N Haese; Jennifer M Burg; Takeshi F Andoh; Iris K A Jones; Craig N Kreklywich; Patricia P Smith; Susan L Orloff; Daniel N Streblow
Journal:  Transpl Infect Dis       Date:  2020-12-07       Impact factor: 2.228

10.  STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants.

Authors:  Tomislav Stojanovic; Andreas H Wagner; Shijun Wang; Eva Kiss; Nicolas Rockstroh; Jens Bedke; Hermann-Josef Gröne; Markus Hecker
Journal:  Basic Res Cardiol       Date:  2009-04-08       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.